[SCHEDULE 13D/A] DallasNews Corporation Series A SEC Filing
Gabelli-affiliated investors disclosed a combined 287,926 shares of DallasNews Corp Series A common stock, representing 6.08% of the 4,739,025 shares outstanding. The filing details individual holdings: Gabelli Funds 128,026 shares (2.70%), Gabelli & Co Investment Advisers/GCIA 102,400 shares (2.16%), GAMCO 47,000 shares (0.99%) and Teton Advisors 10,500 shares (0.22%). The group reports using approximately $540,368 to buy additional shares, including client funds. The filing notes the issuer adopted a 10% poison pill and the reporting persons have not decided how to vote at the issuer's special meeting involving a proposed acquisition by Hearst; they continue to evaluate the situation.
Investitori affiliati a Gabelli hanno dichiarato complessivamente 287.926 azioni ordinarie Serie A di DallasNews Corp, pari al 6,08% delle 4.739.025 azioni in circolazione. La comunicazione dettaglia le partecipazioni individuali: Gabelli Funds 128.026 azioni (2,70%), Gabelli & Co Investment Advisers/GCIA 102.400 azioni (2,16%), GAMCO 47.000 azioni (0,99%) e Teton Advisors 10.500 azioni (0,22%). Il gruppo segnala di aver impiegato circa $540.368 per acquistare azioni aggiuntive, inclusi fondi dei clienti. Il deposito precisa che l'emittente ha adottato una poison pill del 10% e che le persone segnalanti non hanno ancora deciso come votare nella riunione straordinaria dell'emittente relativa a una proposta di acquisizione da parte di Hearst; la situazione è ancora sotto valutazione.
Los inversores afiliados a Gabelli informaron de un total de 287.926 acciones ordinarias Serie A de DallasNews Corp, que representan el 6,08% de las 4.739.025 acciones en circulación. La presentación detalla las posiciones individuales: Gabelli Funds 128.026 acciones (2,70%), Gabelli & Co Investment Advisers/GCIA 102.400 acciones (2,16%), GAMCO 47.000 acciones (0,99%) y Teton Advisors 10.500 acciones (0,22%). El grupo informa haber utilizado aproximadamente $540.368 para comprar acciones adicionales, incluidos fondos de clientes. La presentación señala que el emisor adoptó una poison pill del 10% y que las personas informantes no han decidido aún cómo votarán en la junta extraordinaria del emisor relacionada con una propuesta de adquisición por parte de Hearst; continúan evaluando la situación.
Gabelli 계열 투자자들은 DallasNews Corp 보통주 A 시리즈 287,926주를 합산해 공시했으며, 이는 발행주식 4,739,025주의 6.08%에 해당합니다. 공시에는 각 보유 내역이 상세히 기재되어 있습니다: Gabelli Funds 128,026주(2.70%), Gabelli & Co Investment Advisers/GCIA 102,400주(2.16%), GAMCO 47,000주(0.99%), Teton Advisors 10,500주(0.22%). 이 그룹은 고객 자금을 포함해 추가 주식 매입에 약 $540,368를 사용했다고 보고했습니다. 공시에는 발행사가 10% 포이즌 필을 채택했고, 보고인들이 Hearst의 인수 제안과 관련한 발행사의 임시 주주총회에서 어떻게 표결할지 아직 결정하지 않았으며 상황을 계속 검토 중이라고 적혀 있습니다.
Des investisseurs affiliés à Gabelli ont déclaré un total de 287 926 actions ordinaires de série A de DallasNews Corp, soit 6,08% des 4 739 025 actions en circulation. le dépôt précise les positions individuelles : Gabelli Funds 128 026 actions (2,70%), Gabelli & Co Investment Advisers/GCIA 102 400 actions (2,16%), GAMCO 47 000 actions (0,99%) et Teton Advisors 10 500 actions (0,22%). Le groupe indique avoir utilisé environ $540 368 pour acheter des actions supplémentaires, y compris des fonds de clients. Le dépôt note que l'émetteur a adopté une poison pill de 10% et que les personnes déclarantes n'ont pas encore décidé comment voter lors de l'assemblée extraordinaire de l'émetteur relative à une proposition d'acquisition par Hearst ; elles continuent d'évaluer la situation.
Gabelli-nahe Investoren meldeten zusammen 287.926 Aktien der Serie A von DallasNews Corp, was 6,08% der 4.739.025 ausstehenden Aktien entspricht. Die Einreichung nennt die Einzelpositionen: Gabelli Funds 128.026 Aktien (2,70%), Gabelli & Co Investment Advisers/GCIA 102.400 Aktien (2,16%), GAMCO 47.000 Aktien (0,99%) und Teton Advisors 10.500 Aktien (0,22%). Die Gruppe berichtet, rund $540.368 für den Erwerb zusätzlicher Aktien verwendet zu haben, einschließlich Kundengeldern. Die Einreichung weist darauf hin, dass der Emittent eine 10% Poison Pill eingeführt hat und die meldenden Personen noch nicht entschieden haben, wie sie auf der außerordentlichen Hauptversammlung des Emittenten über den von Hearst vorgeschlagenen Erwerb abstimmen werden; sie prüfen die Lage weiterhin.
- Transparent breakdown of holdings showing aggregate 287,926 shares (6.08%) and individual positions by reporting person
- Disclosure of funds used to acquire additional shares (approximately $540,368), including client funds, clarifies source of purchases
- Filing of long-form Schedule 13D ensures compliance and transparency despite potential eligibility for a short form
- Issuer adopted a 10% poison pill, which the filers state is inconsistent with their proxy voting guidelines
- Reporting persons have not decided how to vote on the proposed acquisition, creating uncertainty for other shareholders
- Significant portion of purchases were made with client funds, which may complicate alignment between principals and advisory clients
Insights
TL;DR Gabelli-related entities hold a meaningful minority stake (6.08%); holdings are split across affiliated advisers and funds.
The disclosed 6.08% position is large enough to warrant market attention but not controlling. Concentration by Gabelli Funds and GCIA (combined ~4.86%) signals coordinated exposure through affiliated investment vehicles. The aggregate cash deployed of $540,368 to acquire additional shares is disclosed and purchases include client funds, indicating portfolio-level activity rather than solely principal accumulation. Absent changes to voting intentions, the stake suggests potential engagement but not an outright control attempt.
TL;DR The filing highlights governance friction: the issuer adopted a 10% poison pill and Gabelli-affiliated holders are evaluating their voting decisions.
The adoption of a 10% poison pill is expressly noted and cited as inconsistent with GAMCO proxy guidelines. The reporting persons explicitly state they have not determined how they will vote on the proposed acquisition and will consider the poison pill among other factors. This disclosure is material to shareholder voting dynamics and indicates potential proxy deliberation rather than an immediate activist escalation.
Investitori affiliati a Gabelli hanno dichiarato complessivamente 287.926 azioni ordinarie Serie A di DallasNews Corp, pari al 6,08% delle 4.739.025 azioni in circolazione. La comunicazione dettaglia le partecipazioni individuali: Gabelli Funds 128.026 azioni (2,70%), Gabelli & Co Investment Advisers/GCIA 102.400 azioni (2,16%), GAMCO 47.000 azioni (0,99%) e Teton Advisors 10.500 azioni (0,22%). Il gruppo segnala di aver impiegato circa $540.368 per acquistare azioni aggiuntive, inclusi fondi dei clienti. Il deposito precisa che l'emittente ha adottato una poison pill del 10% e che le persone segnalanti non hanno ancora deciso come votare nella riunione straordinaria dell'emittente relativa a una proposta di acquisizione da parte di Hearst; la situazione è ancora sotto valutazione.
Los inversores afiliados a Gabelli informaron de un total de 287.926 acciones ordinarias Serie A de DallasNews Corp, que representan el 6,08% de las 4.739.025 acciones en circulación. La presentación detalla las posiciones individuales: Gabelli Funds 128.026 acciones (2,70%), Gabelli & Co Investment Advisers/GCIA 102.400 acciones (2,16%), GAMCO 47.000 acciones (0,99%) y Teton Advisors 10.500 acciones (0,22%). El grupo informa haber utilizado aproximadamente $540.368 para comprar acciones adicionales, incluidos fondos de clientes. La presentación señala que el emisor adoptó una poison pill del 10% y que las personas informantes no han decidido aún cómo votarán en la junta extraordinaria del emisor relacionada con una propuesta de adquisición por parte de Hearst; continúan evaluando la situación.
Gabelli 계열 투자자들은 DallasNews Corp 보통주 A 시리즈 287,926주를 합산해 공시했으며, 이는 발행주식 4,739,025주의 6.08%에 해당합니다. 공시에는 각 보유 내역이 상세히 기재되어 있습니다: Gabelli Funds 128,026주(2.70%), Gabelli & Co Investment Advisers/GCIA 102,400주(2.16%), GAMCO 47,000주(0.99%), Teton Advisors 10,500주(0.22%). 이 그룹은 고객 자금을 포함해 추가 주식 매입에 약 $540,368를 사용했다고 보고했습니다. 공시에는 발행사가 10% 포이즌 필을 채택했고, 보고인들이 Hearst의 인수 제안과 관련한 발행사의 임시 주주총회에서 어떻게 표결할지 아직 결정하지 않았으며 상황을 계속 검토 중이라고 적혀 있습니다.
Des investisseurs affiliés à Gabelli ont déclaré un total de 287 926 actions ordinaires de série A de DallasNews Corp, soit 6,08% des 4 739 025 actions en circulation. le dépôt précise les positions individuelles : Gabelli Funds 128 026 actions (2,70%), Gabelli & Co Investment Advisers/GCIA 102 400 actions (2,16%), GAMCO 47 000 actions (0,99%) et Teton Advisors 10 500 actions (0,22%). Le groupe indique avoir utilisé environ $540 368 pour acheter des actions supplémentaires, y compris des fonds de clients. Le dépôt note que l'émetteur a adopté une poison pill de 10% et que les personnes déclarantes n'ont pas encore décidé comment voter lors de l'assemblée extraordinaire de l'émetteur relative à une proposition d'acquisition par Hearst ; elles continuent d'évaluer la situation.
Gabelli-nahe Investoren meldeten zusammen 287.926 Aktien der Serie A von DallasNews Corp, was 6,08% der 4.739.025 ausstehenden Aktien entspricht. Die Einreichung nennt die Einzelpositionen: Gabelli Funds 128.026 Aktien (2,70%), Gabelli & Co Investment Advisers/GCIA 102.400 Aktien (2,16%), GAMCO 47.000 Aktien (0,99%) und Teton Advisors 10.500 Aktien (0,22%). Die Gruppe berichtet, rund $540.368 für den Erwerb zusätzlicher Aktien verwendet zu haben, einschließlich Kundengeldern. Die Einreichung weist darauf hin, dass der Emittent eine 10% Poison Pill eingeführt hat und die meldenden Personen noch nicht entschieden haben, wie sie auf der außerordentlichen Hauptversammlung des Emittenten über den von Hearst vorgeschlagenen Erwerb abstimmen werden; sie prüfen die Lage weiterhin.